

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21586705 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.01566133 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01566133 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.91427969 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.84589239 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84415002 |
| 7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.79520444 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78025932 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.68701628 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68701628 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68701628 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68701628 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.68701628 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68701628 |
| 15 | hypotonic response (GO:0006971) | 3.53672942 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 3.41628051 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41381156 |
| 18 | response to type I interferon (GO:0034340) | 3.36332515 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.35059140 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.35059140 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.32040322 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 3.31048309 |
| 23 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.27807683 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.27520215 |
| 25 | type I interferon signaling pathway (GO:0060337) | 3.27520215 |
| 26 | detection of other organism (GO:0098543) | 3.26735602 |
| 27 | pinocytosis (GO:0006907) | 3.23575843 |
| 28 | leukocyte aggregation (GO:0070486) | 3.20889744 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 3.17601148 |
| 30 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.17100323 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.14341141 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 3.12184657 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.10532407 |
| 34 | negative T cell selection (GO:0043383) | 3.06231498 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.02089102 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01286929 |
| 37 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00367726 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99571058 |
| 39 | detection of bacterium (GO:0016045) | 2.99149631 |
| 40 | detection of external biotic stimulus (GO:0098581) | 2.98700631 |
| 41 | cellular extravasation (GO:0045123) | 2.96564566 |
| 42 | growth hormone receptor signaling pathway (GO:0060396) | 2.94844185 |
| 43 | positive regulation of humoral immune response (GO:0002922) | 2.90831851 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88680496 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 2.87475171 |
| 46 | thymic T cell selection (GO:0045061) | 2.87192950 |
| 47 | membrane raft organization (GO:0031579) | 2.87119457 |
| 48 | Golgi transport vesicle coating (GO:0048200) | 2.87109370 |
| 49 | COPI coating of Golgi vesicle (GO:0048205) | 2.87109370 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85387573 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 2.84465497 |
| 52 | protein localization to endosome (GO:0036010) | 2.83273207 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83086322 |
| 54 | leukocyte cell-cell adhesion (GO:0007159) | 2.81013815 |
| 55 | neutrophil activation (GO:0042119) | 2.80717933 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 2.80226016 |
| 57 | T cell migration (GO:0072678) | 2.79978160 |
| 58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76538356 |
| 59 | response to interleukin-15 (GO:0070672) | 2.76253986 |
| 60 | regulation of B cell differentiation (GO:0045577) | 2.76124847 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.75736967 |
| 62 | granulocyte activation (GO:0036230) | 2.72031799 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70677693 |
| 64 | embryonic process involved in female pregnancy (GO:0060136) | 2.69003151 |
| 65 | peptide catabolic process (GO:0043171) | 2.68620138 |
| 66 | response to peptidoglycan (GO:0032494) | 2.67696721 |
| 67 | myeloid dendritic cell differentiation (GO:0043011) | 2.67351969 |
| 68 | cellular response to zinc ion (GO:0071294) | 2.67295231 |
| 69 | T cell selection (GO:0045058) | 2.67063719 |
| 70 | interferon-gamma production (GO:0032609) | 2.66443070 |
| 71 | tolerance induction (GO:0002507) | 2.65462698 |
| 72 | response to host immune response (GO:0052572) | 2.64963953 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64963953 |
| 74 | response to laminar fluid shear stress (GO:0034616) | 2.63861705 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 2.63429563 |
| 76 | barbed-end actin filament capping (GO:0051016) | 2.63410389 |
| 77 | positive regulation of interferon-beta production (GO:0032728) | 2.63071528 |
| 78 | regulation of response to interferon-gamma (GO:0060330) | 2.62178039 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.61047631 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60333707 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.56361439 |
| 82 | regulation of natural killer cell differentiation (GO:0032823) | 2.56027897 |
| 83 | regulation of RIG-I signaling pathway (GO:0039535) | 2.55882995 |
| 84 | regulation of necroptotic process (GO:0060544) | 2.53635816 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 2.53617761 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.52854126 |
| 87 | mature B cell differentiation (GO:0002335) | 2.52768387 |
| 88 | cellular response to growth hormone stimulus (GO:0071378) | 2.52052823 |
| 89 | B cell receptor signaling pathway (GO:0050853) | 2.52009279 |
| 90 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51937100 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.51403094 |
| 92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50857902 |
| 93 | response to host (GO:0075136) | 2.50667022 |
| 94 | response to host defenses (GO:0052200) | 2.50667022 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50667022 |
| 96 | response to protozoan (GO:0001562) | 2.50631430 |
| 97 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.49564694 |
| 98 | positive regulation of interleukin-12 production (GO:0032735) | 2.49238799 |
| 99 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49004550 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.48332825 |
| 101 | defense response to protozoan (GO:0042832) | 2.47112746 |
| 102 | hepatocyte apoptotic process (GO:0097284) | 2.45891645 |
| 103 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.44429720 |
| 104 | response to interferon-alpha (GO:0035455) | 2.44388864 |
| 105 | negative regulation of interleukin-12 production (GO:0032695) | 2.43319936 |
| 106 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.43308465 |
| 107 | positive regulation of interleukin-2 production (GO:0032743) | 2.42820996 |
| 108 | positive T cell selection (GO:0043368) | 2.42623698 |
| 109 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.40424792 |
| 110 | positive regulation of B cell mediated immunity (GO:0002714) | 2.40424792 |
| 111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39266203 |
| 112 | germinal center formation (GO:0002467) | 2.38283936 |
| 113 | positive regulation of isotype switching (GO:0045830) | 2.38193620 |
| 114 | B cell mediated immunity (GO:0019724) | 2.38127156 |
| 115 | glomerular visceral epithelial cell development (GO:0072015) | 2.37625384 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 2.36903995 |
| 117 | cytokine secretion (GO:0050663) | 2.36636283 |
| 118 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35948640 |
| 119 | cellular response to interleukin-15 (GO:0071350) | 2.35740214 |
| 120 | regulation of interleukin-12 production (GO:0032655) | 2.35338262 |
| 121 | T-helper cell differentiation (GO:0042093) | 2.35271735 |
| 122 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.35271735 |
| 123 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.34968078 |
| 124 | regulation of cholesterol storage (GO:0010885) | 2.33499442 |
| 125 | regulation of mast cell degranulation (GO:0043304) | 2.33355502 |
| 126 | skin morphogenesis (GO:0043589) | 2.24556437 |
| 127 | definitive hemopoiesis (GO:0060216) | 2.24407270 |
| 128 | mannose metabolic process (GO:0006013) | 2.23053089 |
| 129 | cellular response to ethanol (GO:0071361) | 2.21627160 |
| 130 | positive regulation of macrophage differentiation (GO:0045651) | 2.21145514 |
| 131 | cell adhesion mediated by integrin (GO:0033627) | 2.21115538 |
| 132 | glycosphingolipid catabolic process (GO:0046479) | 2.21006154 |
| 133 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.19373413 |
| 134 | iron ion import (GO:0097286) | 2.18998193 |
| 135 | mature B cell differentiation involved in immune response (GO:0002313) | 2.18014607 |
| 136 | nuclear pore complex assembly (GO:0051292) | 2.17849503 |
| 137 | positive regulation of leukocyte degranulation (GO:0043302) | 2.17379983 |
| 138 | regulation of tolerance induction (GO:0002643) | 2.16053655 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 2.13839663 |
| 140 | stress fiber assembly (GO:0043149) | 2.13468971 |
| 141 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.12891627 |
| 142 | histone H3-K36 demethylation (GO:0070544) | 2.12505444 |
| 143 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.12005025 |
| 144 | regulation of extracellular matrix disassembly (GO:0010715) | 2.11954051 |
| 145 | dendritic cell migration (GO:0036336) | 2.11875376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.25860226 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.68542973 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.16863473 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.89672177 |
| 5 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.84135637 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.74616131 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13049186 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00071275 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.96871389 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.87605520 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78945102 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76799717 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74096417 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66929531 |
| 15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.49153019 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46443482 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40899837 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.36184435 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21000388 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.18306261 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14178631 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10875604 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99056733 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.97873469 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 1.96031123 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92025969 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89261226 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89256069 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85256826 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.80675005 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.78546088 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72801030 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66510879 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62819875 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62816552 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61734594 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60911401 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57361176 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56627090 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55377498 |
| 41 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52286548 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51163861 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.51026936 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50624593 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50030521 |
| 46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49085411 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.47936381 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47734307 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46926608 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46831995 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46179292 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44709423 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43569903 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35838802 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34954365 |
| 56 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34063418 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32998493 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30953780 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28871785 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26078898 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25103392 |
| 62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24603094 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22992354 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21476957 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20015322 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19973792 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19642908 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18628165 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16952887 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16559338 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16433845 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16236420 |
| 73 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16228070 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16120869 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14472161 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14411663 |
| 77 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13443230 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12465238 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11808740 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09062599 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08614207 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08594260 |
| 83 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07575522 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07263877 |
| 85 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06524061 |
| 86 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06451187 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06223026 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05813489 |
| 89 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05630434 |
| 90 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05630434 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05302424 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04630333 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04432228 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02836108 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01770761 |
| 96 | * MAF_26560356_Chip-Seq_TH2_Human | 0.99444817 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99411422 |
| 98 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98583873 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98196523 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98156946 |
| 101 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97437719 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97400668 |
| 103 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97287810 |
| 104 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96959045 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96390259 |
| 106 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93921937 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92088788 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91055584 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90218189 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89946565 |
| 111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89254053 |
| 112 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87641005 |
| 113 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87641005 |
| 114 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87381866 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87177848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.46397946 |
| 2 | MP0000685_abnormal_immune_system | 2.95205531 |
| 3 | MP0005387_immune_system_phenotype | 2.78842475 |
| 4 | MP0001790_abnormal_immune_system | 2.78842475 |
| 5 | MP0009785_altered_susceptibility_to | 2.77675406 |
| 6 | MP0003436_decreased_susceptibility_to | 2.67357556 |
| 7 | MP0005671_abnormal_response_to | 2.56568264 |
| 8 | MP0001800_abnormal_humoral_immune | 2.51894220 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.39240399 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.37745050 |
| 11 | MP0003303_peritoneal_inflammation | 2.35946267 |
| 12 | MP0004510_myositis | 2.31613712 |
| 13 | MP0003724_increased_susceptibility_to | 2.30126331 |
| 14 | MP0005025_abnormal_response_to | 2.27187127 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.24070977 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.23993895 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.20848550 |
| 18 | MP0006082_CNS_inflammation | 2.20753456 |
| 19 | MP0002419_abnormal_innate_immunity | 2.17775507 |
| 20 | MP0002723_abnormal_immune_serum | 2.17518357 |
| 21 | MP0005451_abnormal_body_composition | 2.03673129 |
| 22 | MP0004947_skin_inflammation | 2.00089426 |
| 23 | MP0001819_abnormal_immune_cell | 1.98080693 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.97181839 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.92764053 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.86763721 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.86688617 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.84058022 |
| 29 | MP0002006_tumorigenesis | 1.81245347 |
| 30 | MP0001853_heart_inflammation | 1.77381881 |
| 31 | MP0001873_stomach_inflammation | 1.75957986 |
| 32 | MP0008260_abnormal_autophagy | 1.75099884 |
| 33 | MP0002405_respiratory_system_inflammati | 1.74548117 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.66439491 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.60019612 |
| 36 | MP0002398_abnormal_bone_marrow | 1.57781964 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.57654133 |
| 38 | MP0000716_abnormal_immune_system | 1.56475488 |
| 39 | MP0009278_abnormal_bone_marrow | 1.54559273 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.53529005 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.52773340 |
| 42 | MP0002254_reproductive_system_inflammat | 1.52395513 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.49116950 |
| 44 | MP0003866_abnormal_defecation | 1.43577567 |
| 45 | MP0009764_decreased_sensitivity_to | 1.42282579 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.40712797 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.40493649 |
| 48 | MP0009840_abnormal_foam_cell | 1.40019550 |
| 49 | MP0008469_abnormal_protein_level | 1.38864369 |
| 50 | MP0003828_pulmonary_edema | 1.34903183 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.32681724 |
| 52 | MP0005310_abnormal_salivary_gland | 1.30846234 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.30661085 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.30661085 |
| 55 | MP0005164_abnormal_response_to | 1.29639565 |
| 56 | MP0003448_altered_tumor_morphology | 1.28677613 |
| 57 | MP0002722_abnormal_immune_system | 1.28407298 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.28076557 |
| 59 | MP0002429_abnormal_blood_cell | 1.26315740 |
| 60 | MP0003045_fibrosis | 1.23025067 |
| 61 | MP0000343_altered_response_to | 1.22190908 |
| 62 | MP0004883_abnormal_blood_vessel | 1.22146993 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.20198935 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.17963691 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.14516633 |
| 66 | MP0005360_urolithiasis | 1.13790380 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.12942472 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.12825834 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.10954756 |
| 70 | MP0008004_abnormal_stomach_pH | 1.10654272 |
| 71 | MP0002933_joint_inflammation | 1.08923579 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.08596362 |
| 73 | MP0000858_altered_metastatic_potential | 1.07373967 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.07240956 |
| 75 | MP0005409_darkened_coat_color | 1.05790637 |
| 76 | MP0003252_abnormal_bile_duct | 1.05156380 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.04006374 |
| 78 | MP0005076_abnormal_cell_differentiation | 1.03664371 |
| 79 | MP0005023_abnormal_wound_healing | 0.99816796 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.99267264 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.99227632 |
| 82 | MP0004272_abnormal_basement_membrane | 0.97917564 |
| 83 | MP0003091_abnormal_cell_migration | 0.97751680 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.95590582 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.94878899 |
| 86 | MP0003950_abnormal_plasma_membrane | 0.92872150 |
| 87 | MP0001915_intracranial_hemorrhage | 0.92762328 |
| 88 | MP0001849_ear_inflammation | 0.92547887 |
| 89 | MP0000609_abnormal_liver_physiology | 0.92220173 |
| 90 | MP0009763_increased_sensitivity_to | 0.91092017 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.88785355 |
| 92 | MP0005621_abnormal_cell_physiology | 0.88221536 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.88043448 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.86904029 |
| 95 | MP0003075_altered_response_to | 0.86808384 |
| 96 | MP0000249_abnormal_blood_vessel | 0.86532628 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.86530073 |
| 98 | MP0008057_abnormal_DNA_replication | 0.84998433 |
| 99 | MP0000490_abnormal_crypts_of | 0.84661067 |
| 100 | MP0001851_eye_inflammation | 0.82981047 |
| 101 | MP0005165_increased_susceptibility_to | 0.82508610 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.81536766 |
| 103 | MP0003279_aneurysm | 0.79691409 |
| 104 | MP0000604_amyloidosis | 0.78754200 |
| 105 | MP0002009_preneoplasia | 0.77357723 |
| 106 | MP0005670_abnormal_white_adipose | 0.76025462 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.74678401 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.73009825 |
| 109 | MP0005166_decreased_susceptibility_to | 0.72701266 |
| 110 | MP0004130_abnormal_muscle_cell | 0.71820093 |
| 111 | MP0010630_abnormal_cardiac_muscle | 0.70674874 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.70604471 |
| 113 | MP0005365_abnormal_bile_salt | 0.70601816 |
| 114 | MP0002060_abnormal_skin_morphology | 0.69916340 |
| 115 | MP0010307_abnormal_tumor_latency | 0.69639181 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.66988165 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.66136802 |
| 118 | MP0001663_abnormal_digestive_system | 0.65001770 |
| 119 | MP0001958_emphysema | 0.64459387 |
| 120 | MP0005390_skeleton_phenotype | 0.63857423 |
| 121 | MP0006054_spinal_hemorrhage | 0.63411975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.72849580 |
| 2 | Autoimmune thrombocytopenia (HP:0001973) | 4.54901527 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.35223848 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.22967814 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.95085667 |
| 6 | Recurrent viral infections (HP:0004429) | 3.63438084 |
| 7 | Myositis (HP:0100614) | 3.55555806 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32170957 |
| 9 | Pustule (HP:0200039) | 3.23904900 |
| 10 | Orchitis (HP:0100796) | 3.23123424 |
| 11 | Vasculitis (HP:0002633) | 3.20469665 |
| 12 | Recurrent skin infections (HP:0001581) | 3.17601028 |
| 13 | Colitis (HP:0002583) | 3.16153720 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.15229025 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.12232039 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.08580222 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.06658616 |
| 18 | Inflammation of the large intestine (HP:0002037) | 3.05524278 |
| 19 | Abnormality of the fingertips (HP:0001211) | 3.00638182 |
| 20 | Chronic otitis media (HP:0000389) | 2.98087137 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 2.97851333 |
| 22 | Optic neuritis (HP:0100653) | 2.97851333 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97275301 |
| 24 | Myocardial infarction (HP:0001658) | 2.96324636 |
| 25 | Hematochezia (HP:0002573) | 2.94561063 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94252007 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94252007 |
| 28 | Stomatitis (HP:0010280) | 2.90735204 |
| 29 | Abnormality of T cell number (HP:0011839) | 2.90669505 |
| 30 | Gingivitis (HP:0000230) | 2.86199815 |
| 31 | Gingival bleeding (HP:0000225) | 2.84346293 |
| 32 | T lymphocytopenia (HP:0005403) | 2.83580743 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.81265412 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.80259732 |
| 35 | Increased IgE level (HP:0003212) | 2.78361705 |
| 36 | Periodontitis (HP:0000704) | 2.78302840 |
| 37 | Arterial thrombosis (HP:0004420) | 2.72407360 |
| 38 | Flat acetabular roof (HP:0003180) | 2.70375420 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 2.66908820 |
| 40 | Subacute progressive viral hepatitis (HP:0006572) | 2.65862121 |
| 41 | Cellulitis (HP:0100658) | 2.62121253 |
| 42 | Meningitis (HP:0001287) | 2.59922340 |
| 43 | Abnormality of T cells (HP:0002843) | 2.58496524 |
| 44 | IgM deficiency (HP:0002850) | 2.54399632 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.52285438 |
| 46 | Chronic diarrhea (HP:0002028) | 2.51771438 |
| 47 | Nasal polyposis (HP:0100582) | 2.49133668 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.48195044 |
| 49 | Spondylolisthesis (HP:0003302) | 2.47338153 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.45569196 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.44942419 |
| 52 | Esophageal varix (HP:0002040) | 2.43339604 |
| 53 | Viral hepatitis (HP:0006562) | 2.38731821 |
| 54 | Leukocytosis (HP:0001974) | 2.38310656 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35478895 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35478895 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35478895 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.34960774 |
| 59 | IgA deficiency (HP:0002720) | 2.33896982 |
| 60 | Thyroiditis (HP:0100646) | 2.33746753 |
| 61 | Protrusio acetabuli (HP:0003179) | 2.32915011 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.32760492 |
| 63 | Obstructive lung disease (HP:0006536) | 2.32637367 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32637367 |
| 65 | Vertebral compression fractures (HP:0002953) | 2.31919206 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.31375648 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.31326216 |
| 68 | Eosinophilia (HP:0001880) | 2.31089659 |
| 69 | Hemoptysis (HP:0002105) | 2.30959087 |
| 70 | Arterial tortuosity (HP:0005116) | 2.30906629 |
| 71 | Epistaxis (HP:0000421) | 2.30254270 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.28792902 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.28067861 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28067861 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.25780202 |
| 76 | Osteomyelitis (HP:0002754) | 2.25643351 |
| 77 | Broad face (HP:0000283) | 2.24370886 |
| 78 | Prolonged bleeding time (HP:0003010) | 2.22146928 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.14692905 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 2.14689347 |
| 81 | Vascular tortuosity (HP:0004948) | 2.13764394 |
| 82 | Increased IgM level (HP:0003496) | 2.12479435 |
| 83 | Abnormal platelet volume (HP:0011876) | 2.11773556 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 2.10127674 |
| 85 | Emphysema (HP:0002097) | 2.09910770 |
| 86 | Polycythemia (HP:0001901) | 2.09854836 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.09282749 |
| 88 | Lymphopenia (HP:0001888) | 2.08798946 |
| 89 | Chest pain (HP:0100749) | 2.07688787 |
| 90 | Spinal cord lesions (HP:0100561) | 2.06488122 |
| 91 | Syringomyelia (HP:0003396) | 2.06488122 |
| 92 | Pulmonary embolism (HP:0002204) | 2.06357926 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.05992570 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.05506160 |
| 95 | Combined immunodeficiency (HP:0005387) | 2.04356848 |
| 96 | Aortic aneurysm (HP:0004942) | 2.04281338 |
| 97 | Nephritis (HP:0000123) | 2.03345548 |
| 98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02765403 |
| 99 | Cervical subluxation (HP:0003308) | 2.02557466 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.99756079 |
| 101 | Dysostosis multiplex (HP:0000943) | 1.99690966 |
| 102 | Joint swelling (HP:0001386) | 1.98579272 |
| 103 | Premature rupture of membranes (HP:0001788) | 1.98462802 |
| 104 | Dilatation of the ascending aorta (HP:0005111) | 1.97799363 |
| 105 | B lymphocytopenia (HP:0010976) | 1.97256132 |
| 106 | Abnormality of B cell number (HP:0010975) | 1.97256132 |
| 107 | Systemic lupus erythematosus (HP:0002725) | 1.96969857 |
| 108 | Peritonitis (HP:0002586) | 1.96928139 |
| 109 | Amyloidosis (HP:0011034) | 1.95331633 |
| 110 | Impaired platelet aggregation (HP:0003540) | 1.93408539 |
| 111 | Abnormal platelet function (HP:0011869) | 1.93408539 |
| 112 | Encephalitis (HP:0002383) | 1.93343714 |
| 113 | Restrictive lung disease (HP:0002091) | 1.93336933 |
| 114 | Abnormality of oral frenula (HP:0000190) | 1.92976801 |
| 115 | Granulocytopenia (HP:0001913) | 1.92491238 |
| 116 | Tetraparesis (HP:0002273) | 1.91881790 |
| 117 | Urticaria (HP:0001025) | 1.89767072 |
| 118 | Aortic dissection (HP:0002647) | 1.89037015 |
| 119 | Skin ulcer (HP:0200042) | 1.89010010 |
| 120 | Thick nail (HP:0001805) | 1.88785855 |
| 121 | Loss of speech (HP:0002371) | 1.88760715 |
| 122 | Petechiae (HP:0000967) | 1.88632530 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.87722544 |
| 124 | Mitral stenosis (HP:0001718) | 1.87540955 |
| 125 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87392363 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.86397655 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86397655 |
| 128 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84979618 |
| 129 | Micronodular cirrhosis (HP:0001413) | 1.83427458 |
| 130 | Aneurysm (HP:0002617) | 1.82147633 |
| 131 | Ankyloglossia (HP:0010296) | 1.81103090 |
| 132 | Fatigue (HP:0012378) | 1.77696561 |
| 133 | Abnormality of the peritoneum (HP:0002585) | 1.77434471 |
| 134 | Wormian bones (HP:0002645) | 1.77342049 |
| 135 | Absent frontal sinuses (HP:0002688) | 1.76219904 |
| 136 | Glucose intolerance (HP:0000833) | 1.75465429 |
| 137 | Deep venous thrombosis (HP:0002625) | 1.75054338 |
| 138 | Malnutrition (HP:0004395) | 1.74502934 |
| 139 | Abnormality of complement system (HP:0005339) | 1.74498317 |
| 140 | Cerebral aneurysm (HP:0004944) | 1.72908215 |
| 141 | Abnormal glucose tolerance (HP:0001952) | 1.72613319 |
| 142 | Short nail (HP:0001799) | 1.72424063 |
| 143 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71432351 |
| 144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71432351 |
| 145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71432351 |
| 146 | Thin bony cortex (HP:0002753) | 1.71117814 |
| 147 | Coarse hair (HP:0002208) | 1.70076241 |
| 148 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.68162140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.51476857 |
| 2 | MAP3K14 | 3.16984981 |
| 3 | TXK | 2.79847205 |
| 4 | TYK2 | 2.77424995 |
| 5 | PRPF4B | 2.63343475 |
| 6 | JAK3 | 2.62262821 |
| 7 | IRAK3 | 2.51858083 |
| 8 | TBK1 | 2.47973730 |
| 9 | JAK1 | 2.46718294 |
| 10 | IKBKE | 2.33522468 |
| 11 | ERN1 | 2.31609294 |
| 12 | IRAK4 | 2.15978057 |
| 13 | EPHB1 | 2.12378895 |
| 14 | FGFR4 | 2.08834534 |
| 15 | TAOK3 | 1.95413227 |
| 16 | TGFBR2 | 1.92549929 |
| 17 | SMG1 | 1.90510650 |
| 18 | STK10 | 1.88645743 |
| 19 | EPHA2 | 1.79591429 |
| 20 | IKBKB | 1.77744561 |
| 21 | ZAP70 | 1.76936183 |
| 22 | FGFR3 | 1.74975197 |
| 23 | BLK | 1.74879826 |
| 24 | SCYL2 | 1.67541562 |
| 25 | MST4 | 1.64930042 |
| 26 | CDK12 | 1.60526344 |
| 27 | TTN | 1.56674943 |
| 28 | CHUK | 1.53308592 |
| 29 | KIT | 1.52615555 |
| 30 | ITK | 1.51980838 |
| 31 | CSK | 1.43934210 |
| 32 | LMTK2 | 1.39062228 |
| 33 | MAP3K13 | 1.38396367 |
| 34 | PDGFRA | 1.37043053 |
| 35 | BTK | 1.35682081 |
| 36 | TEC | 1.35492633 |
| 37 | MET | 1.32578175 |
| 38 | TRIB3 | 1.29500422 |
| 39 | PTK6 | 1.28789719 |
| 40 | BMPR2 | 1.28530837 |
| 41 | MAP3K10 | 1.28124145 |
| 42 | RIPK4 | 1.27004282 |
| 43 | TRPM7 | 1.25732250 |
| 44 | ICK | 1.23793880 |
| 45 | NEK9 | 1.23144136 |
| 46 | SIK1 | 1.22819672 |
| 47 | PAK4 | 1.21512188 |
| 48 | CAMK1D | 1.18500342 |
| 49 | EPHA3 | 1.17007632 |
| 50 | HCK | 1.14534812 |
| 51 | LRRK2 | 1.14251138 |
| 52 | MAP2K3 | 1.14194008 |
| 53 | JAK2 | 1.09801254 |
| 54 | FGR | 1.07786877 |
| 55 | LCK | 1.07742217 |
| 56 | SYK | 1.07677641 |
| 57 | PIM1 | 1.05942191 |
| 58 | CSF1R | 1.05246526 |
| 59 | MELK | 1.01524104 |
| 60 | YES1 | 1.01506773 |
| 61 | NLK | 1.01458809 |
| 62 | RPS6KA4 | 1.01012129 |
| 63 | MAP3K2 | 1.00263364 |
| 64 | PKN2 | 0.93249062 |
| 65 | RIPK1 | 0.92142746 |
| 66 | MAP3K1 | 0.91395655 |
| 67 | DMPK | 0.88457249 |
| 68 | STK4 | 0.85213513 |
| 69 | MARK3 | 0.84708957 |
| 70 | GRK6 | 0.84680609 |
| 71 | MAP3K7 | 0.83828103 |
| 72 | CDC42BPA | 0.83063704 |
| 73 | CAMK1G | 0.74467567 |
| 74 | KDR | 0.71018691 |
| 75 | PIK3CG | 0.70981027 |
| 76 | PRKCQ | 0.70476637 |
| 77 | TIE1 | 0.69898056 |
| 78 | KSR2 | 0.69896041 |
| 79 | MAP3K6 | 0.68686363 |
| 80 | NME2 | 0.68120818 |
| 81 | CDK4 | 0.67544523 |
| 82 | PRKG2 | 0.66731408 |
| 83 | LYN | 0.64388025 |
| 84 | PRKAA2 | 0.62435416 |
| 85 | EEF2K | 0.62196551 |
| 86 | MAP3K8 | 0.61505830 |
| 87 | WNK1 | 0.61125294 |
| 88 | FLT3 | 0.60774280 |
| 89 | PIK3CA | 0.60677196 |
| 90 | PDGFRB | 0.60353441 |
| 91 | PIM2 | 0.60321278 |
| 92 | IRAK1 | 0.59590478 |
| 93 | MATK | 0.59571199 |
| 94 | BMX | 0.58966086 |
| 95 | PRKD2 | 0.58889328 |
| 96 | STK24 | 0.58434947 |
| 97 | FRK | 0.57106826 |
| 98 | RPS6KB2 | 0.55808063 |
| 99 | STK3 | 0.55770410 |
| 100 | CDK6 | 0.55106583 |
| 101 | RET | 0.54770831 |
| 102 | TESK2 | 0.54226805 |
| 103 | NUAK1 | 0.54177322 |
| 104 | STK38 | 0.54122577 |
| 105 | CDK9 | 0.53195289 |
| 106 | MAPKAPK2 | 0.52309956 |
| 107 | ABL1 | 0.51769416 |
| 108 | SIK2 | 0.49191615 |
| 109 | MARK2 | 0.48397383 |
| 110 | MAP3K3 | 0.47775202 |
| 111 | PDK1 | 0.46093647 |
| 112 | EGFR | 0.45848658 |
| 113 | NEK6 | 0.45306632 |
| 114 | MOS | 0.45161414 |
| 115 | HIPK2 | 0.44716261 |
| 116 | MAPK7 | 0.43604431 |
| 117 | RPS6KA6 | 0.42043347 |
| 118 | MYLK | 0.41207230 |
| 119 | SGK3 | 0.40741548 |
| 120 | MAPK11 | 0.39269461 |
| 121 | PRKD1 | 0.35623177 |
| 122 | BRD4 | 0.35195303 |
| 123 | MTOR | 0.32923974 |
| 124 | CLK1 | 0.32467657 |
| 125 | FES | 0.32427527 |
| 126 | SIK3 | 0.32249384 |
| 127 | PDPK1 | 0.32045165 |
| 128 | PRKCH | 0.31389896 |
| 129 | OBSCN | 0.30904086 |
| 130 | PTK2 | 0.30764407 |
| 131 | MAPK12 | 0.30178026 |
| 132 | MST1R | 0.30169911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70388321 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66527121 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65832419 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36163242 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.35319828 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29891420 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22680162 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19228316 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.11870337 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.10537092 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01782731 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97417022 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94883186 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.84806238 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81022254 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80782236 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74027592 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67513820 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.63461651 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.53701151 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53007119 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.49355628 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44871428 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44044508 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41320988 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38145450 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.38109409 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.37934683 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35604684 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33305288 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.32527361 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30326603 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.26521007 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26328441 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.22907016 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.19402002 |
| 37 | * Apoptosis_Homo sapiens_hsa04210 | 1.17316472 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17257751 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17162976 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16014168 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.14944674 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13805632 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13267281 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.08026387 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08003569 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.05606578 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.04608854 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.02147719 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.01103637 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98439258 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.98290590 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96886891 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.96564589 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94361928 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.93206907 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92353279 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.91925583 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90341972 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88569863 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88371376 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.87580037 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.81313645 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80697144 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.80046469 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78642604 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76111435 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75858027 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74857944 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72949897 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72607884 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71776446 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70693965 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70569350 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69426849 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68070074 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.65685059 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64986449 |
| 78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63232286 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62083316 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61881062 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61312401 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61153480 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61152661 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61050375 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60596108 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59759320 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59660500 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58546453 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58176240 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57929233 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.57461399 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56814742 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56679328 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54915872 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53278063 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52995440 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.52883532 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52662379 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52298092 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51033711 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50940624 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50779896 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50725308 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49163277 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48695372 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48105610 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48062169 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46755738 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45412160 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43948333 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41681793 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41239949 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39572270 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39370821 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38880888 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.38876334 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38192335 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36687108 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35551262 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35432321 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34722055 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.34004625 |

